نتایج جستجو برای: hydroxamic acid

تعداد نتایج: 747666  

Journal: :Molecules 2017
Beáta Fekete Márta Palkó Matti Haukka Ferenc Fülöp

From 2-aminonorbornene hydroxamic acids, a simple and efficient method for the preparation of pyrrolo[1,2-a]pyrimidine enantiomers is reported. The synthesis is based on domino ring-closure followed by microwave-induced retro Diels-Alder (RDA) protocols, where the chirality of the desired products is transferred from norbornene derivatives. The stereochemistry of the synthesized compounds was p...

Journal: :IOSR Journal of Environmental Science, Toxicology and Food Technology 2016

2010
Shaoteng Han Takuya Fukazawa Tomoki Yamatsuji Junji Matsuoka Hiroyuki Miyachi Yutaka Maeda Mary Durbin Yoshio Naomoto

Histone deacetylase (HDAC) inhibitors arrest cancer cell growth and cause apoptosis with low toxicity thereby constituting a promising treatment for cancer. In this study, we investigated the anti-tumor activity in lung cancer cells of the novel cyclic amide-bearing hydroxamic acid based HDAC inhibitors SL142 and SL325. In A549 and H441 lung cancer cells both SL142 and SL325 induced more cell g...

Journal: :American journal of nuclear medicine and molecular imaging 2013
Changning Wang Thomas E Eessalu Vanessa N Barth Charles H Mitch Florence F Wagner Yijia Hong Ramesh Neelamegam Frederick A Schroeder Edward B Holson Stephen J Haggarty Jacob M Hooker

Hydroxamic acid-based histone deacetylase inhibitors (HDACis) are a class of molecules with therapeutic potential currently reflected in the use of suberoylanilide hydroxamic acid (SAHA; Vorinostat) to treat cutaneous T-cell lymphomas (CTCL). HDACis may have utility beyond cancer therapy, as preclinical studies have ascribed HDAC inhibition as beneficial in areas such as heart disease, diabetes...

Nasser Dallali, Y. K. Agrawal

Magnesium is extracted with a chloroform solution of N-p-tolyl-2- thenohydroxamic acid (PTTHA) from aqueous solution of pH 9.5 .Mg-PTTHA complex is colourless and the colour is developed by adding quinalizarin into the extract. lmax and e of the complex are 590nm and 2.8´103 Lmol -1cm-1respectively.Most common  ions do not interfere in the determination of magnesi...

Journal: :The Journal of antibiotics 1976
N Tsuji M Kobayashi K Nagashima Y Wakisaka K Koizumi

A new antibiotic, trichostatin, was isolated from the metabolites of strains of Streptomyces hygroscopicus. It is active against trichophytons and some fungi. The structure was determined to be a derivative of a primary hydroxamic acid by chemical and spectroscopic evidences.

Journal: :Chemical communications 2013
Florian Brandhuber Michael Zengerle Luzian Porwol Anne Bierwisch Marianne Koller Georg Reiter Franz Worek Stefan Kubik

Arrangement of several hydroxamic acid-derived substituents along the cavity of a cyclodextrin ring leads to compounds that detoxify tabun in TRIS-HCl buffer at physiological pH and 37.0 °C with half-times as low as 3 min.

Journal: :Blood 2012
Sajal K Ghosh Susan P Perrine Robert M Williams Douglas V Faller

Induction of EBV lytic-phase gene expression, combined with exposure to an antiherpes viral drug, represents a promising targeted therapeutic approach to EBV-associated lymphomas. Short-chain fatty acids or certain chemotherapeutics have been used to induce EBV lytic-phase gene expression in cultured cells and mouse models, but these studies generally have not translated into clinical applicati...

Journal: :Blood 2006
Sonia Carta Sara Tassi Claudia Semino Gianluca Fossati Paolo Mascagni Charles A Dinarello Anna Rubartelli

A number of agents reducing interleukin-1beta (IL-1beta) activity are being developed as novel immunomodulatory and anti-inflammatory therapies. However, the elucidation of their molecular mechanism of action is required in the context of medical management of inflammatory diseases. Inhibitors of histone deacetylases (HDACs) are promising anticancer agents with pleiotropic activities. Of these,...

2006
Sonia Carta Sara Tassi Claudia Semino Gianluca Fossati Paolo Mascagni Charles A. Dinarello Anna Rubartelli

A number of agents reducing interleukin-1 (IL-1 ) activity are being developed as novel immunomodulatory and anti-inflammatory therapies. However, the elucidation of their molecular mechanism of action is required in the context of medical management of inflammatory diseases. Inhibitors of histone deacetylases (HDACs) are promising anticancer agents with pleiotropic activities. Of these, subero...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید